Westport Resources Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Westport Resources Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-794	Closed	-$41K	–	853
2015 Q4	$41K	Hold	794	–	–	0.01%	494
2015 Q3	$37K	Sell	794 -286	-26%	-$17.2K	0.01%	514
2015 Q2	$67K	Hold	1,080	–	–	0.02%	447
2015 Q1	$67K	Hold	1,080	–	–	0.02%	469
2014 Q4	$58K	Hold	1,080	–	–	0.02%	510
2014 Q3	$57K	Hold	1,080	–	–	0.02%	524
2014 Q2	$56K	Hold	1,080	–	–	0.02%	531
2014 Q1	$51K	Hold	1,080	–	–	0.01%	565
2013 Q4	$48K	Hold	1,080	–	–	0.01%	577
2013 Q3	$42K	Hold	1,080	–	–	0.01%	572
2013 Q2	$38K	Buy	+1,080	New	+$36.5K	0.01%	569

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

KHLMVGHM

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet Tel Aviv, Israel $2.44B AUM 24.95% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Westport Resources Management's XPH Position: Q1 2016 in Review

Westport Resources Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2016, closing a stake of 794 shares — an estimated $41K sold.

Westport Resources Management first reported a position in XPH in Q2 2013 and held it in 11 quarters. The position peaked at $67K in Q2 2015. 71 funds tracked by Wall St. Rank hold XPH as of Q1 2016.

Westport Resources Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2016 after selling out during the quarter.
Westport Resources Management sold 794 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2016, an estimated $41K.
Westport Resources Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and held it in 11 quarters.
Westport Resources Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $67K in Q2 2015.
71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2016.

Based on Westport Resources Management's 13F filing for Q1 2016, filed 16 May 2016.